Bachem Holding (Suzhou): difference between revisions
Diff·revision 47 → 48·15:32, 7 Jul 2025
Difference between revision 47 and revision 48 of Bachem Holding (Suzhou). 5 lines changed; the page grew by 271 bytes.
| Revision 47 — 18:10, 28 Jun 2025 StubSorterBot (talk) bot: update parent category chain 10,130 bytes ±0 | Revision 48 — 15:32, 7 Jul 2025 LedgerLysander (talk) add {{refimprove}}10,401 bytes +271 | ||
|---|---|---|---|
| 86 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 86 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 87 | 87 | ||
| + | 88 | == Further reading == | |
| + | 89 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 90 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 91 | ||
| 88 | == See also == | 92 | == See also == |
| 89 | * [[Certificate of analysis]] | 93 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 93 | * [[Research use only]] | 97 | * [[Research use only]] |
| 94 | * [[Peptide supply chain]] | 98 | * [[Peptide supply chain]] |
| + | 99 | * [[Blind sampling]] | |
| 95 | 100 | ||
| 96 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} | 101 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} |